ANALISIS EFEKTIVITAS BIAYA (COST EFFECTIVENESS ANALYSIS) PADA PENGOBATAN PASIEN MALARIA FALCIPARUM DI RSUD NABIRE

Authors

  • Ninsi L. Refasi

DOI:

https://doi.org/10.35799/pha.7.2018.19365

Abstract

ANALISIS EFEKTIVITAS BIAYA (COST EFFECTIVENESS ANALYSIS) PADA PENGOBATAN PASIEN MALARIA FALCIPARUM DI RSUD NABIRE

Ninsi Lelantina Refasi1), Widya Astuty Lolo1), Widdhi Bodhi1)

  1)Program Studi Farmasi FMIPA UNSRAT Manado, 95115

 

ABSTRACT

Cost Effectiveness Analysis (CEA) is a pharmacoeconomic method described in a cost-effectiveness ratio in order to assist making the effective drug selection decisions by benefit and cost. The aim of this study was to establish a more cost effectiveness therapy between the use of a combination of quinine-primaquine and a combination of artesunate-primaquine in falciparum malaria patient. This research uses descriptive research method with retrospective data retrieval. The sample in this study consisted of 36 patients, which are 23 patients using quinine-primaquine and 13 patient using artesunate-primaquine. The result of this study obtained from the comparison of ACER value of ACER value quinine-primaquine (Rp. 15.523) greater than the value of ACER artesunate-primaquine (Rp. 12.479), and also seen on ICER calculation result -0.284, so the use of more expensive drugs effective artesunate-primaquine compared with quinine-primaquine.

Keywords : Cost Effectiveness Analysis, Malaria Falciparum, Combination of Quinine-Primaquine, Combination of Artesunate-Primaquine

 

ABSTRAK

 

Analisis Efektivitas biaya (CEA) merupakan metode farmakoekonomi yang digambarkan dalam rasio biaya-efektivitas agar dapat membantu pengambilan keputusan dalam memilih obat yang efektif secara manfaat dan biaya. Tujuan penelitian ini untuk menentukkan terapi yang lebih cost-effective antara penggunaan kombinasi kina-primakuin dan kombinasi artesunat-primakuin pada pasien malaria falciparum. Penelitian ini menggunakan metode penelitian deskriptif dengan pengambilan data secara retrospektif. Sampel pada penelitian ini terdiri dari 36 pasien yaitu 23 pasien yang menggunakan kombinasi kina-primakuin dan 13 pasien yang menggunakan kombinasi artesunat-primakuin. Hasil penelitian ini diperoleh dari perbandingan nilai ACER yaitu nilai  ACER kombinasi kina-primakuin (Rp.15.523) lebih besar dari nilai ACER kombinasi artesunat-primakuin (Rp.12.479), serta dilihat juga pada hasil perhitungan ICER yaitu -0.284,  sehingga penggunaan obat yang lebih cost-effective yaitu kombinasi artesunat-primakuin dibanding dengan kombinasi kina-primakuin.

Kata kunci : Analisis Efektivitas Biaya, Malaria Falciparum, Kombinasi Kina-Primakuin, Kombinasi Artesunat-Primakuin

 

 

 

 

Downloads

Published

2018-04-25

How to Cite

Refasi, N. L. (2018). ANALISIS EFEKTIVITAS BIAYA (COST EFFECTIVENESS ANALYSIS) PADA PENGOBATAN PASIEN MALARIA FALCIPARUM DI RSUD NABIRE. PHARMACON, 7(2). https://doi.org/10.35799/pha.7.2018.19365

Issue

Vol. 7 No. 2 (2018): Pharmacon

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)